Mpox (Monkeypox): We Must Not Let Our Guard Down
Global Virus NetworkThis month, the World Health Organization declared an end to the Mpox emergency and urged a transition to a “robust, proactive and sustainable” response to Mpox.
This month, the World Health Organization declared an end to the Mpox emergency and urged a transition to a “robust, proactive and sustainable” response to Mpox.
The Global Virus Network (GVN) recently appointed Andrea Ridenour as Senior Vice President of Corporate Partnerships & Development and Robert Frederick as Chief Content Officer.
The recent public health emergency declarations in New York and London due to polio infections and detection of the virus in these cities’ wastewater strongly indicate that polio is no longer close to being eradicated.
The Global Virus Network (GVN), representing 71 Centers of Excellence and 9 Affiliates in 40 countries comprising foremost experts in every class of virus causing disease in humans, and the Oswaldo Cruz Foundation (Fiocruz) in Rio de Janeiro, Brazil announced the addition of the Laboratory for Clinical Research in Neuroinfections (LabClin-Neuro), the Principal National Reference Centre for Neurovirology Infections at the National Institute of Health located at Fiocruz, as GVN’s newest Center of Excellence.
Christian Bréchot, MD, PhD, President of the Global Virus Network (GVN), Associate Vice President for International Partnerships and Innovation at the University of South Florida and Professor of the Division of Infectious Disease, Department of Internal Medicine at USF Health Morsani College of Medicine, the GVN Southeast U.S. Regional Headquarters today issued a statement on the surge of SARS-CoV-2.
The Global Virus Network (GVN) announced eleven members of the 2022 GVN Rising Star Mentorship Program. The newly elected members span eight countries around the globe.
The Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 39 countries comprising foremost experts in every class of virus causing disease in humans, and the Mahidol University in Thailand announced the addition of the Mahidol Virus Network as GVN’s newest Center of Excellence.
Two new studies from the Global Virus Network (GVN) in partnership with the Petroleum Industry Health Organization of Iran provide evidence that getting the oral polio vaccine made from live, weakened poliovirus may protect people from COVID-19 infection by stimulating the immune system.
The Global Virus Network (GVN), representing 69 Centers of Excellence and 11 Affiliates in 37 countries comprising foremost experts in every class of virus causing disease in humans and some animals, and the Aegis Consortium at the University of Arizona Health Sciences announced today the induction of Aegis as GVN’s newest Center of Excellence.
The Global Virus Network (GVN), representing 69 Centers of Excellence and 11 Affiliates in 37 countries comprising foremost experts in every class of virus causing disease in humans, and the Centre Scientifique de Monaco (CSM) announced CSM as GVN’s newest Affiliate.
The three awardees will receive training and mentorship to help support and propel their rising careers in virology
The Global Virus Network (GVN) is an apolitical global organization comprised of the world’s leading scientists, including those from Russia and Ukraine, who specialize in education and research for the purpose of protecting mankind from viral proliferation and viruses that cause pandemics. The scientists of the Global Virus Network collaborate to alleviate the pain and suffering caused by viral pathogens and to mitigate the threat they pose to mankind.
Baltimore, Maryland, USA, February 8, 2021: The Global Virus Network (GVN), representing 68 Centers of Excellence and 10 Affiliates in 36 countries comprising foremost experts in every class of virus causing disease in humans, and the Centre for the AIDS Programme of Research in South Africa (CAPRISA) in Durban announced the addition of CAPRISA as GVN’s newest Center of Excellence.
The Global Virus Network (GVN), representing 67 Centers of Excellence and 10 Affiliates in 36 countries comprising foremost experts in every class of virus causing disease in humans, and the Scientific Platform Pasteur-University of São Paulo (SPPU) announced the addition of the SPPU as GVN’s newest Center of Excellence.
The Global Virus Network (GVN), representing 66 Centers of Excellence and 10 Affiliates in 35 countries comprising foremost experts in every class of virus causing disease in humans, and the Institute of Biomedical Systems and Biotechnologies at Peter the Great St. Petersburg Polytechnic University (SPbPU) announced the addition of the Institute as GVN’s newest Center of Excellence.
The current COVID-19 pandemic has again emphasized the importance of accurate, rapid, and massively deployed diagnostics to effectively contain viral transmission.
“Twindemic” is a term that has not yet been in the headlines but is likely to become part of our lexicon as the summer progresses.
With the advent of the school year and children returning to in-person classes, there comes a concern over consequences with respect to the spread of the highly contagious Delta variant. It has been accepted that children are not as susceptible to viral infection and severe illness as adults. However, the current prevalence of the Delta variant is producing different outcomes.
The Global Virus Network (GVN), representing 63 Centers of Excellence and 11 Affiliates in 34 countries comprising foremost experts in every class of virus causing disease in humans, and the Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation [Institute for Health Research, Epidemiological Surveillance and Training], or the IRESSEF, announced the addition of the IRESSEF as GVN’s newest Center of Excellence.
The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, today announced the election of eight distinguished global leaders to its Board of Directors.